» Articles » PMID: 32977386

Quality of Life of Cancer Patients Treated with Chemotherapy

Overview
Publisher MDPI
Date 2020 Sep 26
PMID 32977386
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

Life-quality tests are the basis for assessing the condition of oncological patients. They allow for obtaining valuable information from the patients regarding not only the symptoms of disease and adverse effects of the treatment but also assessment of the psychological, social and spiritual aspects. Taking into account assessment of the quality of life made by the patient in the course of disease has a positive effect on the well-being of patients, their families and their caregivers as well as on satisfaction with the interdisciplinary and holistic oncological care. : A population-based, multi-area cross-sectional study was conducted among patients with cancer in the study in order to assess their life quality. The method used in the study was a clinical interview. Quality of life was measured using the EQ-5D-5L Quality of Life Questionnaire, the Karnofsky Performance Status, our own symptom checklist, Edmonton Symptom Assessment and Visual Analogue Scale. In the subjective assessment of fitness, after using the Karnofsky fitness index, it was shown that 28% (95% CI (confidence interval): 27-30) of patients declared the ability to perform normal physical activity. In the assessment the profile, quality of life and psychometric properties of EQ-5D-5L, it was shown that patients had the most severe problems in terms of self-care (81%, 95% CI: 76-89) and feeling anxious and depressed (63%, 95% CI: 60-68). Cancer undoubtedly has a negative impact on the quality of life of patients, which is related to the disease process itself, the treatment used and the duration of the disease.

Citing Articles

Resilience as a mediator of quality of life in cancer patients in healthcare services.

Caldiroli C, Sarandacchi S, Tomasuolo M, Diso D, Castiglioni M, Procaccia R Sci Rep. 2025; 15(1):8599.

PMID: 40075138 PMC: 11904231. DOI: 10.1038/s41598-025-93008-2.


Preoperative Visitation Effect on Quality of Life of Patients Undergoing Transarterial Chemoembolization for Hepatocellular Carcinoma.

Ishikawa T, Suzuki A, Yamamoto H, Arita N, Matsuhashi Y, Kobayashi N Cancer Diagn Progn. 2025; 5(2):230-237.

PMID: 40034951 PMC: 11871864. DOI: 10.21873/cdp.10434.


Symptoms, Symptom Profiles, and Healthcare Utilization in Patients with Hematologic Malignancies: A Retrospective Observational Cohort Study and Latent Class Analysis.

Booker R, Sawatzky R, Sinnarajah A, Qi S, Link C, Watson L Curr Oncol. 2025; 32(2).

PMID: 39996862 PMC: 11854205. DOI: 10.3390/curroncol32020062.


Quality-adjusted survival in patients with metastatic colorectal cancer treated with fruquintinib plus best supportive care: results from FRESCO-2.

Stintzing S, Tabernero J, Satoh T, Dasari A, Lonardi S, Eng C ESMO Open. 2025; 10(3):104297.

PMID: 39985889 PMC: 11904580. DOI: 10.1016/j.esmoop.2025.104297.


Knowledge, attitudes, and practices regarding whole-course management among patients with gastrointestinal cancers: a cross-sectional study.

Huang M, Feng L, Ren H, Yuan Z, Liu C, Liu Y World J Surg Oncol. 2025; 23(1):45.

PMID: 39924482 PMC: 11809093. DOI: 10.1186/s12957-025-03668-7.


References
1.
Smyth E, Shen W, Bowman L, Peterson P, John W, Melemed A . Patient-reported pain and other quality of life domains as prognostic factors for survival in a phase III clinical trial of patients with advanced breast cancer. Health Qual Life Outcomes. 2016; 14:52. PMC: 4807577. DOI: 10.1186/s12955-016-0449-z. View

2.
Annunziata M, Muzzatti B, Flaiban C, Gipponi K, Carnaghi C, Tralongo P . Long-term quality of life profile in oncology: a comparison between cancer survivors and the general population. Support Care Cancer. 2017; 26(2):651-656. DOI: 10.1007/s00520-017-3880-8. View

3.
Kroenke K, Theobald D, Wu J, Loza J, Carpenter J, Tu W . The association of depression and pain with health-related quality of life, disability, and health care use in cancer patients. J Pain Symptom Manage. 2010; 40(3):327-41. PMC: 2934745. DOI: 10.1016/j.jpainsymman.2009.12.023. View

4.
Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S . The prevalence of psychological distress by cancer site. Psychooncology. 2001; 10(1):19-28. DOI: 10.1002/1099-1611(200101/02)10:1<19::aid-pon501>3.0.co;2-6. View

5.
Siegel R, Miller K, Jemal A . Cancer statistics, 2018. CA Cancer J Clin. 2018; 68(1):7-30. DOI: 10.3322/caac.21442. View